Anthony Lucci

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint Circulating tumour cells in non-metastatic breast cancer: a prospective study
    Anthony Lucci
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Lancet Oncol 13:688-95. 2012
  2. ncbi request reprint Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011
    Anthony Lucci
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:3657-63. 2007
  3. ncbi request reprint Assessment of the current Medicare reimbursement system for breast cancer operations
    Anthony Lucci
    Michael E DeBakey Department of Surgery and the Breast Care Center at Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA
    Ann Surg Oncol 11:1037-44. 2004
  4. doi request reprint Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow
    Anthony Lucci
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Breast Cancer Res Treat 117:61-8. 2009
  5. pmc Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma
    John R Hyngstrom
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Melanoma Res 23:290-7. 2013
  6. doi request reprint Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer
    Min Yi
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Surg 196:81-7. 2008
  7. doi request reprint Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer
    Balraj Singh
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin Exp Metastasis 27:233-40. 2010
  8. pmc Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients
    Sharon B Chang
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 17:2764-72. 2010
  9. pmc Biology, treatment, and outcome in very young and older women with DCIS
    Rosalinda Alvarado
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 19:3777-84. 2012
  10. doi request reprint American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns
    Abigail S Caudle
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 19:3144-51. 2012

Collaborators

Detail Information

Publications82

  1. doi request reprint Circulating tumour cells in non-metastatic breast cancer: a prospective study
    Anthony Lucci
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Lancet Oncol 13:688-95. 2012
    ..Our aim was to establish if circulating tumour cells predicted worse outcome in patients with non-metastatic breast cancer...
  2. ncbi request reprint Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011
    Anthony Lucci
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:3657-63. 2007
    ..The current study compares complications associated with SLN dissection (SLND) plus ALND, versus SLND alone...
  3. ncbi request reprint Assessment of the current Medicare reimbursement system for breast cancer operations
    Anthony Lucci
    Michael E DeBakey Department of Surgery and the Breast Care Center at Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA
    Ann Surg Oncol 11:1037-44. 2004
    ..Since no mechanism exists to consider outcomes in calculating reimbursements, we hypothesized that Medicare reimbursements do not correlate with outcomes for different breast cancer operations...
  4. doi request reprint Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow
    Anthony Lucci
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Breast Cancer Res Treat 117:61-8. 2009
    ....
  5. pmc Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma
    John R Hyngstrom
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Melanoma Res 23:290-7. 2013
    ..Informed consent for melanoma patients undergoing lymph node surgery should include a discussion of the risks of postoperative lymphedema. ..
  6. doi request reprint Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer
    Min Yi
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Surg 196:81-7. 2008
    ..We determined the incidence of positive sentinel lymph nodes (SLNs) in patients with ductal carcinoma in situ (DCIS) or microinvasive breast cancer (MIC) and the predictive factors of SLN metastasis in these patients...
  7. doi request reprint Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer
    Balraj Singh
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin Exp Metastasis 27:233-40. 2010
    ..05). However, CTCE-9908 as a single therapy inhibited organ-specific metastasis to leg (P < 0.05 by chi-squared test and by two-sample t-test)...
  8. pmc Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients
    Sharon B Chang
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 17:2764-72. 2010
    ..We prospectively assessed the incidence, risk factors, and costs associated with wound complications and lymphedema in melanoma patients undergoing inguinal lymph node dissection (ILND)...
  9. pmc Biology, treatment, and outcome in very young and older women with DCIS
    Rosalinda Alvarado
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 19:3777-84. 2012
    ..This study examines a modern cohort of women with ductal carcinoma-in-situ (DCIS) in order to identify potential differences in clinical presentation, treatments, and outcome based on age...
  10. doi request reprint American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns
    Abigail S Caudle
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 19:3144-51. 2012
    ..The ACOSOG Z0011 trial has been described as practice-changing. The goal of this study was to determine the impact of the trial on surgeon practice patterns at our institution...
  11. doi request reprint Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy
    Ranjna Sharma
    Department of Surgical Oncology, Plastic Surgery, Radiation Oncology, and Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Plast Reconstr Surg 127:1763-72. 2011
    ....
  12. doi request reprint HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
    Julie E Lang
    Department of Surgical Oncology, MD Anderson Cancer Center, Advanced Research Center for Microscopic Disease, The University of Texas, Houston, TX 77030, USA
    Breast Cancer Res Treat 113:501-7. 2009
    ..We hypothesized that primary tumor characteristics would predict the likelihood of identifying CTCs in patients with operable breast cancer...
  13. doi request reprint Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation
    Judy C Boughey
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    Ann Surg Oncol 16:1606-11. 2009
    ..This study was intended to evaluate the impact of neoadjuvant chemotherapy in ILC on breast-conserving surgery (BCS) rates...
  14. doi request reprint Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs
    Gary V Walker
    Department of Radiation Oncology, The Morgan Welch Inflammatory Breast Cancer Clinic, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 83:1381-6. 2012
    ..The purpose of this study was to define how pretreatment PET/CT studies affected postmastectomy radiation treatment (PMRT) planning decisions for IBC...
  15. pmc Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision
    Min Yi
    Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX 77030, USA
    J Clin Oncol 30:600-7. 2012
    ..The aim of our study was to evaluate a published nomogram from Memorial Sloan-Kettering Cancer Center to predict for risk of IBTR in patients with DCIS from our institution...
  16. doi request reprint Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death
    Robert E Roses
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 18:2873-8. 2011
    ..The rare patient diagnosed with pure ductal carcinoma-in-situ (DCIS) develops distant breast cancer metastases (DM). We sought to identify clinical and pathologic predictors of DM...
  17. doi request reprint Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer
    Laura S Dominici
    Department of Surgical Oncology, Brigham and Women s Hospital, Boston, MA, USA
    Cancer 116:2884-9. 2010
    ..To the authors' knowledge, the rate of eradication of biopsy-proven axillary lymph node metastases with trastuzumab-containing neoadjuvant chemotherapy regimens has not been previously reported...
  18. pmc Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer
    Judy C Boughey
    Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Surg 244:464-70. 2006
    ..To determine the effect of preoperative chemotherapy on the volume of tissue excised and the number of breast operations in patients undergoing breast-conserving therapy (BCT)...
  19. pmc Role of COX-2 in tumorospheres derived from a breast cancer cell line
    Balraj Singh
    Department of Surgical Oncology and Advanced Research Center for Microscopic Disease, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Surg Res 168:e39-49. 2011
    ..Cyclooxygenase-2 (COX-2) expression in primary breast cancer predicts tumor cell dissemination to bone marrow, which is a risk factor for recurrence and distant metastasis. "Stem-like" phenotype may be important in cancer metastasis...
  20. pmc Lymph node ratio predicts disease-specific survival in melanoma patients
    Yan Xing
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 115:2505-13. 2009
    ..The objectives of this analysis were to compare various measures associated with lymph node (LN) dissection and to identify threshold values associated with disease-specific survival (DSS) outcomes in patients with melanoma...
  21. doi request reprint Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer
    Carolyn Hall
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 118:342-8. 2012
    ..Neoadjuvant chemotherapy (NACT) is effective in reducing the size of primary tumors or eradicating lymph node metastases before surgery, but little is known regarding the presence or significance of DTCs after NACT...
  22. doi request reprint How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?
    Min Yi
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 113:30-7. 2008
    ..The objective of this study was to determine how many SLNs need to be removed for accurate lymph node staging and which patient and tumor characteristics influence this number...
  23. doi request reprint Does blue dye contribute to success of sentinel node mapping for breast cancer?
    Taewoo Kang
    Department of Surgical Oncology, M D Anderson Cancer Center, The University of Texas, Houston, TX, USA
    Ann Surg Oncol 17:280-5. 2010
    ..We sought to evaluate the utilization of blue dye in addition to radioisotope and its relative contribution to sentinel lymph node (SLN) mapping at a high-volume institution...
  24. doi request reprint Inflammatory breast cancer: the disease, the biology, the treatment
    Fredika M Robertson
    Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    CA Cancer J Clin 60:351-75. 2010
    ..This review examines IBC's unique clinical presentation, pathology, epidemiology, imaging, and biology and details current multidisciplinary management of the disease, which comprises systemic therapy, surgery, and radiation therapy...
  25. doi request reprint Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy
    Min Yi
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 117:916-24. 2011
    ..The purpose of this study was to examine the rates of local, regional, and systemic recurrence, and survival in breast cancer patients who underwent skin-sparing mastectomy (SSM) or conventional mastectomy (CM) at our institution...
  26. doi request reprint Detection of minimal residual disease in blood and bone marrow in early stage breast cancer
    Savitri Krishnamurthy
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 116:3330-7. 2010
    ..In this study, the authors investigated the occurrence of CTCs and DTCs in women with early stage breast cancer and evaluated the correlation of their presence with other prognostic markers...
  27. pmc Inflammatory breast cancer: what we know and what we need to learn
    Hideko Yamauchi
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Oncologist 17:891-9. 2012
    ..We review the current status of multidisciplinary care for patients with inflammatory breast cancer (IBC) and discuss what further research is needed to advance the care of patients with this disease...
  28. pmc Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass
    Henry M Kuerer
    Department of Surgical Oncology, DCIS Discovery Enterprise, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77230 1402, USA
    Breast Cancer Res Treat 133:1131-41. 2012
    ..Furthermore, there was no significant difference in risk of recurrence between diabetic patients receiving metformin or not. In conclusion, higher BMI is not associated with adverse biologic features or prognosis in patients with DCIS...
  29. doi request reprint Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning
    Min Yi
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, TX, USA
    Ann Surg 253:572-9. 2011
    ..We utilized 2 different methods and compared sensitivities and specificities between them. Our goal was to determine whether distinguishing NP from TR had prognostic value...
  30. pmc Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer
    Dongwei Zhang
    Breast Cancer Translational Research Laboratory, Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 15:6639-48. 2009
    ..Epidermal growth factor receptor (EGFR) expression is an independent poor prognostic factor in IBC. The purpose of this study was to determine the effect on IBC tumorigenicity and metastasis of blocking the EGFR pathway...
  31. doi request reprint A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer
    Eugene H Huang
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Surg Res 155:231-6. 2009
    ..Our purpose was to determine whether inhibition of CXCR4 with a peptide-based antagonist would reduce tumor growth and metastasis of breast cancer...
  32. doi request reprint Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy
    Ranjna Sharma
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 17:2899-908. 2010
    ..We sought to determine present-day locoregional recurrence (LRR) rates to better understand the role of postmastectomy radiotherapy (PMRT) in women with 0 to 3 positive lymph nodes...
  33. doi request reprint Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells
    Balraj Singh
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    J Surg Res 147:240-6. 2008
    ..We also analyzed cell cultures grown as mammospheres to determine whether COX2 expression affects the cancer-initiating ("stem") cell phenotype in MCF7 cells...
  34. doi request reprint Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients
    Carolyn Hall
    Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 17:3252-8. 2010
    ..Conversely, late recurrences are seen in estrogen receptor (ER)-positive (luminal) cancers. Disseminated tumor cells (DTCs) may be responsible for late recurrences. We compared rates of DTCs in basal and luminal subtypes...
  35. ncbi request reprint Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node
    Nazanin Khakpour
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Surg 190:598-601. 2005
    ....
  36. pmc Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis
    Yan Xing
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 116:2234-41. 2010
    ..The objective of this analysis was to provide melanoma-specific CS estimates to help clinicians promote more informed patient decision making...
  37. doi request reprint Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
    Yun Gong
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 117:5476-84. 2011
    ..In this retrospective study, the authors examined EZH2 expression in IBC tumors and evaluated the relation between EZH2 expression and patient survival...
  38. ncbi request reprint COX-2 induces IL-11 production in human breast cancer cells
    Balraj Singh
    Department of Surgical Oncology, University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Surg Res 131:267-75. 2006
    ..Since breast cancers that overexpress COX-2 are associated with a higher rate of metastasis to bone, we hypothesized that COX-2 expression in tumor cells would induce IL-11...
  39. ncbi request reprint Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy
    Laura A Lambert
    Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
    Ann Surg Oncol 13:310-20. 2006
    ..To assess the generalizable use of this nomogram, validation analysis was performed by using an external database...
  40. pmc Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype
    James M Reuben
    Department of Hematopathology, Unit 54, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Eur J Cancer 47:1527-36. 2011
    ..Therefore, we assessed the presence of Aldefluor(+) epithelial (CD326(+)CD45(dim)) cells for the presence of the CD44(+)CD24(lo) phenotype in BM of patients with primary breast cancer (PBC)...
  41. doi request reprint A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer
    Savitri Krishnamurthy
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 115:1555-62. 2009
    ....
  42. pmc Selection of metastatic breast cancer cells based on adaptability of their metabolic state
    Balraj Singh
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    PLoS ONE 7:e36510. 2012
    ..As we decreased the number of cancer cells in xenografts, lung metastasis and then primary tumor growth was impaired in mice injected with parental cell line, but not in mice injected with Gln-ind cells...
  43. pmc Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy
    Michal Mego
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Int J Cancer 130:808-16. 2012
    ..In summary, our results demonstrate that CTCs with EMT phenotype may occur in the peripheral circulation of patients with PBC and that NAT is unable to eliminate CTCs undergoing EMT...
  44. pmc Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311)
    Melinda M Mortenson
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    World J Surg Oncol 6:63. 2008
    ....
  45. pmc Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines
    Balraj Singh
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Surg Res 163:235-43. 2010
    ..Herein we tested the hypothesis that celecoxib-resistance involves selection of cancer cells that overexpress COX-2...
  46. pmc Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4
    Fredika M Robertson
    Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 116:2806-14. 2010
    ....
  47. pmc Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast
    Henry M Kuerer
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 117:39-47. 2011
    ..Through this study, the authors sought to investigate the biologic and immunologic effects of preoperative trastuzumab in patients with ductal carcinoma in situ (DCIS) of the breast...
  48. ncbi request reprint Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center
    Kari M Rosenkranz
    MD Anderson Cancer Center, Department of Surgical Oncology, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Am J Surg 192:541-4. 2006
    ..We performed a retrospective review of the very elderly population treated at our institution in order to assess treatment patterns and the safety of therapy in an older population...
  49. pmc Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy
    Richard W Joseph
    Department of Melanoma Medical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 17:4882-91. 2011
    ..However, little is known how clinical and pathologic features impact TIL outgrowth isolated from metastatic melanoma tumors...
  50. ncbi request reprint The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy
    Florentia Peintinger
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:1248-54. 2006
    ....
  51. doi request reprint Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone
    Annika Card
    Department of Plastic Surgery and the Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Plast Reconstr Surg 130:1169-78. 2012
    ..To determine whether breast cancer reconstruction has an impact on the incidence of breast cancer-related lymphedema, the authors compared its incidence in patients who underwent mastectomy with reconstruction versus mastectomy alone...
  52. pmc Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review
    Kate D Cromwell
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Melanoma Res 22:376-85. 2012
    ..As the number of melanoma survivors increases, it will be critical to examine the benefits and costs of various follow-up strategies to establish consensus guidelines for melanoma post-treatment surveillance...
  53. ncbi request reprint Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Julie E Lang
    The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Unit 444, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 7:1463-72. 2007
    ..The purpose of this report is to review the data regarding CTCs and DTCs in patients with operable breast cancer...
  54. pmc Invasive lobular carcinoma predicts micrometastasis in breast cancer
    Sarah M Gainer
    Department of Surgical Oncology, The University of Texas, MD, Anderson Cancer Center, Houston, Texas 77030, USA
    J Surg Res 177:93-6. 2012
    ..Disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) have been implicated in recurrence. The purpose of this study was to determine whether DTCs and CTCs are associated with ILCs in stage I-III breast cancer...
  55. pmc Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome
    Shaheenah Dawood
    Departments of Breast Medical Oncology, Pathology, Quantitative Sciences, Radiotherapy and Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas and Department of Medical Oncology, Dubai Hospital, Dubai, UAE
    Breast J . 2010
    ..CXCR4 may represent a novel therapeutic target...
  56. pmc Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer
    Jing Li
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Oncologist 16:1675-83. 2011
    ..However, these findings have not been confirmed for inflammatory breast cancer (IBC), which has different biological features than non-IBC...
  57. pmc Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
    Bisrat G Debeb
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Mol Cancer 9:180. 2010
    ..Herein we fully characterize cancer stem cell-like features in 293T human embryonic kidney cells...
  58. ncbi request reprint Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells
    Balraj Singh
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Surg Res 140:220-6. 2007
    ..We hypothesized that the induction of genomic instability is a major mechanism through which COX-2 contributes to breast cancer progression...
  59. ncbi request reprint Intramammary lymph node presenting as the primary breast mass in infiltrating lobular carcinoma
    Andreana L Rivera
    Department of Pathology, Baylor College of Medicine, Houston, Texas, USA
    Curr Surg 63:107-9. 2006
  60. ncbi request reprint Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin)
    Ricardo J Gonzalez
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Breast J 13:72-5. 2007
    ....
  61. ncbi request reprint Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer
    Balraj Singh
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Surg Res 134:44-51. 2006
    ..The purpose of this study was to test our hypothesis that tumors that overexpress COX-2 induce IL-8 production...
  62. doi request reprint Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
    Elizabeth FitzSullivan
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 20:4103-12. 2013
    ..We sought to determine the incidence and consequences of close margins in patients with DCIS treated with mastectomy...
  63. doi request reprint Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons
    Sarah M Gainer
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Surg Oncol 19:3152-8. 2012
    ..The current study was undertaken to evaluate the impact of Z0011 on surgical practice nationally...
  64. ncbi request reprint COX-2 overexpression increases motility and invasion of breast cancer cells
    Balraj Singh
    Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Oncol 26:1393-9. 2005
    ..In this study, we conclude that COX-2 overexpression in human breast cancer cells enhances cell motility and invasiveness thus suggesting a mechanism of COX-2 mediated metastasis...
  65. ncbi request reprint Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancer
    Angela Shoher
    Department of Surgery, Baylor College of Medicine, and The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Curr Surg 63:207-12. 2006
    ..The purpose of this study was to determine whether routine LS enhances rate of identification of sentinel nodes (SN), and if findings on LS alter either the SLND procedure or the subsequent patient management...
  66. doi request reprint Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
    Takayuki Iwamoto
    Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Breast Cancer Res Treat 125:785-95. 2011
    ..IBC tumors can be divided into molecular and clinical subtypes similar to those of non-IBC. Clinical subtypes of IBC show molecular differences compared with similar subtypes of non-IBC...
  67. ncbi request reprint Emerging patterns of practice in the implementation and application of sentinel lymph node biopsy in breast cancer patients in the United States
    Angela Shoher
    Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
    J Surg Oncol 83:65-7. 2003
  68. doi request reprint Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery
    Judy C Boughey
    Department of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
    Am J Surg 198:720-5. 2009
    ..The goal of the current study was to evaluate the effect of regional anesthesia using paravertebral block (PVB) on postoperative pain after breast surgery...
  69. ncbi request reprint Mastectomy performed with scissors following tumescent solution injection
    Angela Shoher
    Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
    J Surg Oncol 83:191-3. 2003
  70. pmc Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions
    Bisrat G Debeb
    Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 76:889-95. 2010
    ..From these data, we hypothesized that VA would fail to radiosensitize breast cancer stem/progenitor cells grown to three-dimensional (3D) mammospheres...
  71. doi request reprint Melanoma adrenal metastasis: natural history and surgical management
    Elizabeth A Mittendorf
    Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Am J Surg 195:363-8; discussion 368-9. 2008
    ..Few data exist regarding melanoma metastasis to the adrenal gland. We reviewed our experience to determine the natural history of this condition and the appropriate role for surgical intervention...
  72. ncbi request reprint Atypical dermatofibrosarcoma protuberans in the breast
    Vijay Ramakrishnan
    Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
    Breast J 11:217-8. 2005
  73. ncbi request reprint Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results
    Andrea E Van Pelt
    Department of Surgery, Methodist Hospital, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Clin Breast Cancer 4:348-53. 2003
    ..A high rate of brain metastasis was noted, particularly in patients with baseline metastatic disease...
  74. ncbi request reprint Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells
    Young Jin Suh
    Department of Surgical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Surgery 138:422-30. 2005
    ..We have shown that adenoviral delivery of mda-7 (Ad-mda7) in breast cancer down-regulates Akt. We hypothesized that combining Ad-mda7 and celecoxib could mediate tumor suppression in COX-2 overexpressing breast cancer cells...
  75. ncbi request reprint Surgical treatment of pregnancy associated breast cancer
    Kari M Rosenkranz
    The University of Texas M D Anderson Cancer Center, Houston, 77230 1402, USA
    Breast Dis 23:87-93. 2005
    ..Neoadjuvant chemotherapy, sentinel node biopsy and breast conservation are now considered safe modalities in properly chosen pregnant patients...
  76. doi request reprint Oncoplastics: techniques for reconstruction of partial breast defects based on tumor location
    Sarah M Gainer
    Department of Surgical Oncology, The Methodist Hospital, Houston, Texas 77030, USA
    J Surg Oncol 103:341-7. 2011
    ..The field of oncoplastics has also become increasingly popular and seeks to prevent these contour deformities during BCT. This review approaches oncoplastic reconstruction by outlining different techniques based on tumor location...
  77. ncbi request reprint Role of cyclooxygenase-2 in breast cancer
    Balraj Singh
    Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
    J Surg Res 108:173-9. 2002
    ..It is likely that the COX-2 inhibitors will be effective in the treatment regimens involving combination chemotherapies...
  78. ncbi request reprint Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial
    Lee Gravatt Wilke
    Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
    Ann Surg Oncol 13:491-500. 2006
    ..Surgical complications associated with the sentinel lymph node biopsy surgical procedure are reported...
  79. ncbi request reprint Re: Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer, by van Rijk MC, Tanis PJ, Nieweg OE, et al
    Anthony Lucci
    J Surg Oncol 94:266-8. 2006
  80. ncbi request reprint Is axillary dissection needed when the sentinel node is positive? No: it is time to rethink axillary lymph node dissection when the sentinel node is positive
    Anthony Lucci
    J Surg Oncol 97:201-2. 2008
  81. ncbi request reprint A gene signature in breast cancer
    Wendy A Woodward
    N Engl J Med 356:1887-8; author reply 1887-8. 2007
  82. doi request reprint Orthopedic surgery implications of breast cancer
    German A Marulanda
    Department of Orthopedics and Sports Medicine, University of South Florida, 3500 E Fletcher Avenue, Suite 511, MDC106 Tampa, FL 33613, USA
    Expert Rev Anticancer Ther 8:949-56. 2008
    ..Orthopedic surgeons should establish an active role in the multidisciplinary treatment of patients with breast cancer...